Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P1YH
|
|||
| Former ID |
DIB000922
|
|||
| Drug Name |
S-1746
|
|||
| Indication | Cerebrovascular ischaemia [ICD-11: 8B1Z; ICD-10: I67.8; ICD-9: 434.91] | Discontinued in Phase 1 | [1] | |
| Company |
Shionogi & Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glutamate receptor AMPA (GRIA) | Target Info | Antagonist | [2] |
| N-methyl-D-aspartate receptor (NMDAR) | Target Info | Antagonist | [2] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016496) | |||
| REF 2 | 1,026 experimental treatments in acute stroke. Ann Neurol. 2006 Mar;59(3):467-77. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.